{"version":"1.0","provider_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","provider_url":"https:\/\/www.izb-online.de\/en\/","title":"4SC has grown up","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"XJgXO7L1FQ\"><a href=\"https:\/\/www.izb-online.de\/en\/4sc-has-grown-up\/\">4SC has grown up<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.izb-online.de\/en\/4sc-has-grown-up\/embed\/#?secret=XJgXO7L1FQ\" width=\"600\" height=\"338\" title=\"&#8220;4SC has grown up&#8221; &#8212; Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" data-secret=\"XJgXO7L1FQ\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.izb-online.de\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/03\/Bild-1_4SC_beitragsbild_version-quer.jpg","thumbnail_width":400,"thumbnail_height":255,"description":"In 1999, when 4SC moved into the IZB, the company evaluated potential drug candidates and offered these research services to biopharmaceutical companies. Currently, the product pipeline comprises several epigenetically active cancer drugs undergoing trials from advanced preclinical research to late-stage clinical development."}